Niklas Czeloth
- Immunology top 2%
- T-cell and B-cell Immunology 12
- Immunotherapy and Immune Responses 9
- Immune Cell Function and Interaction 9
- Biosimilars and Bioanalytical Methods 4
- Immunology and Allergy top 5%
- Oncology top 10%
- Hematology top 10%
- Dermatology top 5%
-
- Pharmaceutical studies and practices 4
-
- Sphingolipid Metabolism and Signaling 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Health Systems, Economic Evaluations, Quality of Life 2
- Co-authors
- Reinhold FörsterMariette MohauptZiba KiafardGabriele HintzenThomas BlankensteinLars OhlJörg ZwirnerGolo Henning
- Journals
- The Journal of Immunology (4 papers)Expert Opinion on Biological Therapy (2 papers)Expert Opinion on Investigational Drugs (2 papers)
- Partner nations
- GermanyUnited StatesNew Zealand
In The Last Decade
Niklas Czeloth
20 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 85
- Immunology 1.4k
- Immunology and Allergy 112
- Oncology 428
- Hematology 114
- Dermatology 83
Countries citing papers authored by Niklas Czeloth
This map shows the geographic impact of Niklas Czeloth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Niklas Czeloth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Niklas Czeloth more than expected).
Fields of papers citing papers by Niklas Czeloth
This network shows the impact of papers produced by Niklas Czeloth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Niklas Czeloth. The network helps show where Niklas Czeloth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Niklas Czeloth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 18 | |
| 2 | 2019 | 21 | |
| 3 | 2017 | 23 | |
| 4 | 2016 | 50 | |
| 5 | 2015 | 4 | |
| 6 | 2014 | 29 | |
| 7 | 2013 | 11 | |
| 8 | 2012 | 50 | |
| 9 | 2011 | 19 | |
| 10 | 2010 | 57 | |
| 11 | (1125) - Selective Activation of Naturally Occurring Regulatory T Cells (Tregs) by the Monoclonal Antibody (mAb) BT-061. Markers of Clinical Activity and Early Phase II Results in Patients with Rheumatoid Arthritis (RA) | 2010 | 4 |
| 12 | 2009 | 51 | |
| 13 | 2009 | 113 | |
| 14 | 2009 | 38 | |
| 15 | 2007 | 50 | |
| 16 | 2007 | 58 | |
| 17 | 2007 | 195 | |
| 18 | 2005 | 34 | |
| 19 | 2005 | 166 | |
| 20 | CCR7 Governs Skin Dendritic Cell Migration under Inflammatory and Steady-State Conditionsbreakdown → | 2004 | 804 |
About Niklas Czeloth
Niklas Czeloth is a scholar working on Immunology, Immunology and Allergy, Pediatrics, Perinatology and Child Health, Radiology, Nuclear Medicine and Imaging and Hematology, having authored 20 papers that have together received 1.8k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (12 papers), Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (9 papers), Biosimilars and Bioanalytical Methods (4 papers), Pharmaceutical studies and practices (4 papers), Sphingolipid Metabolism and Signaling (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Health Systems, Economic Evaluations, Quality of Life (2 papers). The work is most often cited by research in Immunology (1.4k citations), Immunology and Allergy (112 citations), Oncology (428 citations), Hematology (114 citations) and Dermatology (83 citations). Niklas Czeloth has collaborated with scholars based in Germany, United States and New Zealand. Frequent co-authors include Reinhold Förster, Mariette Mohaupt, Ziba Kiafard, Gabriele Hintzen, Thomas Blankenstein, Lars Ohl, Jörg Zwirner, Golo Henning, Günter Bernhardt and Oliver Pabst. Their work appears in journals such as The Journal of Immunology, Expert Opinion on Biological Therapy, Expert Opinion on Investigational Drugs, European Journal of Immunology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.